The National Pharmaceutical Pricing Authority (NPPA) has extended the price cap on knee implants by a month to September 15. The pricing regulator is meanwhile deliberating on the ceiling prices of the medical device. The price cap was valid till August 15.
The NPPA had allowed firms to take a 10 per cent hike for their knee implant products last year. The regulator had slashed prices of knee implants by almost 70 per cent around 2017 using the extraordinary powers granted under the Drug Price Control Order (DPCO), 2013.
Knee implants are devices used to replace parts of damaged knee